HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Further Evidence That Lanreotide Reduces Liver Growth in Patients With Polycystic Liver Disease, But Not the End of the Story.

AuthorsFrederik Temmerman, Frederik Nevens
JournalGastroenterology (Gastroenterology) Vol. 157 Issue 2 Pg. 298-299 (08 2019) ISSN: 1528-0012 [Electronic] United States
PMID31260661 (Publication Type: Editorial, Comment)
Chemical References
  • Peptides, Cyclic
  • lanreotide
  • Somatostatin
Topics
  • Cysts
  • Humans
  • Kidney Diseases
  • Liver Diseases
  • Peptides, Cyclic
  • Somatostatin (analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: